title: [New TBE vaccine formulations--free of proteineous stabilizer and preservatives. Overview of clinical studies and first year post-marketing experience].
authors.affiliation: Klinische Forschung & Medical Affairs, Chiron Vaccines, Postfach 1630, D-35006 Marburg. olaf_zent@chiron.com
authors.forename: O
authors.initials: O
authors.lastname: Zent
authors.forename: Ch
authors.initials: Ch
authors.lastname: Wittermann
authors.forename: A
authors.initials: A
authors.lastname: Banzhoff
authors.forename: A
authors.initials: A
authors.lastname: Plentz
authors.forename: W
authors.initials: W
authors.lastname: Jilg
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002626:Chemistry, Pharmaceutical; D002648:Child; D004669:Encephalitis Viruses, Tick-Borne / Q000276:immunology*; D004675:Encephalitis, Tick-Borne / Q000276:immunology / Q000517:prevention & control*; D005858:Germany; D006801:Humans; D012449:Safety; D013997:Time Factors; D014611:Vaccination; D014765:Viral Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry / Q000276:immunology
chemical_list: D014765:Viral Vaccines